Alzheimer's disease: Aβ-fibrinogen interaction inhibitor improves cognition in AD.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2014 AND VI 13 AND IP 7
Results: 30
1
2
InterMune and Boehringer blaze trails for idiopathic pulmonary fibrosis drugs.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 483, doi. 10.1038/nrd4382
- By:
- Publication type:
- Article
3
Memory: Fingolimod modulates bad memories.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 496, doi. 10.1038/nrd4379
- By:
- Publication type:
- Article
4
The malignant melanoma landscape.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 491, doi. 10.1038/nrd4326
- By:
- Publication type:
- Article
5
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 477, doi. 10.1038/nrd4383
- Publication type:
- Article
6
Metabolic disorders: Pumping up muscle mitochondria.
- Published in:
- 2014
- By:
- Publication type:
- journal article
7
Can we safely target the WNT pathway?
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 513, doi. 10.1038/nrd4233
- By:
- Publication type:
- Article
8
Neuroendocrinology: A long pain-free life.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 495, doi. 10.1038/nrd4373
- By:
- Publication type:
- Article
9
Muscarinic acetylcholine receptors: novel opportunities for drug development.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 549, doi. 10.1038/nrd4295
- By:
- Publication type:
- Article
10
Anticancer drugs: Clues to metformin's anticancer actions.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 496, doi. 10.1038/nrd4377
- By:
- Publication type:
- Article
11
Takeda's integrin inhibitor scores inflammatory bowel disease approvals.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 485, doi. 10.1038/nrd4388
- Publication type:
- Article
12
The toolbox is open, but who should pay for the job?
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 479, doi. 10.1038/nrd4367
- By:
- Publication type:
- Article
13
FDA releases first chronic fatigue guidance.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 560, doi. 10.1038/nrd4362
- Publication type:
- Article
14
The BACE race is on.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 560, doi. 10.1038/nrd4361
- Publication type:
- Article
15
Alzheimer's disease: Aβ-fibrinogen interaction inhibitor improves cognition in AD.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 494, doi. 10.1038/nrd4370
- By:
- Publication type:
- Article
16
Cancer: Targeting IL-17 in pancreatic cancer.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 493, doi. 10.1038/nrd4372
- By:
- Publication type:
- Article
17
Tatsuya Kondo.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 490, doi. 10.1038/nrd4376
- Publication type:
- Article
18
Recent patents related to muscarinic acetylcholine receptors.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 489, doi. 10.1038/nrd4385
- Publication type:
- Article
19
Emerging targets in neuroinflammation-driven chronic pain.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 533, doi. 10.1038/nrd4334
- By:
- Publication type:
- Article
20
Can you trust your animal study data?
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 560, doi. 10.1038/nrd4090-c1
- By:
- Publication type:
- Article
21
Biogen Idec storms haemophilia markets.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 485, doi. 10.1038/nrd4387
- Publication type:
- Article
22
Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 487, doi. 10.1038/nrd4375
- By:
- Publication type:
- Article
23
GSK's darapladib failures dim hopes for anti-inflammatory heart drugs.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 481, doi. 10.1038/nrd4381
- By:
- Publication type:
- Article
24
Market watch: Upcoming catalysts in Q3 2014.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 486, doi. 10.1038/nrd4374
- By:
- Publication type:
- Article
25
GSK launches mega trial of p38 MAPK inhibitor in acute coronary syndrome.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 485, doi. 10.1038/nrd4386
- Publication type:
- Article
26
Tackling the cancer stem cells - what challenges do they pose?
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 497, doi. 10.1038/nrd4253
- By:
- Publication type:
- Article
27
Vaccines: Nanorings boost vaccine adjuvant effects.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 496, doi. 10.1038/nrd4380
- By:
- Publication type:
- Article
28
Anticancer drugs: Hitting SYK in B-ALL leukaemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
29
Neurodegenerative disease: Citalopram drives down amyloid-β.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 496, doi. 10.1038/nrd4378
- By:
- Publication type:
- Article
30
Supreme Court reins in ambiguous patents.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 7, p. 488, doi. 10.1038/nrd4384
- Publication type:
- Article